TPM2 attenuates progression of prostate cancer by blocking PDLIM7-mediated nuclear translocation of YAP1.

Wu, Zonglong; Ge, Liyuan; Ma, Lulin; Lu, Min; Song, Yimeng; Deng, Shaohui; Duan, Peichen; Du, Tan; Wu, Yaqian; Zhang, Zhanyi; Zhang, Shudong.

Afiliação

Wu Z; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Ge L; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Ma L; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Lu M; Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.
Song Y; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Deng S; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Duan P; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Du T; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Wu Y; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Zhang Z; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Zhang S; Department of Urology, Peking University Third Hospital, Beijing, 100191, People's Republic of China. zhangshudong@bjmu.edu.cn.